ProQR Therapeutics N.V.

ProQR Therapeutics N.V.'s next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, ProQR Therapeutics N.V. has 138.09M shares outstanding.

As of June 30, 2026, ProQR Therapeutics N.V. maintains a current ratio of 3.49, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, ProQR Therapeutics N.V. posted a negative return on equity (ROE) of -57.40, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -31.01, reflecting losses generated across the asset base. The company generates approximately 2.02M in revenue per employee across its workforce of 181.78, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, ProQR Therapeutics N.V. recorded 518,978.18 in income tax expense. The company reported a pretax loss of -838.57M and -839.09M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on August 17, 2026, ProQR Therapeutics N.V.'s stock has gained approximately 0.00% over the past 52 weeks.

Over the twelve months ended June 30, 2026, ProQR Therapeutics N.V. generated 366.52M in revenue and converted that into -839.09M in net income, yielding earnings per share of -8.01. EBITDA reached -800.44M, while operating income came in at -855.36M.

As of June 30, 2026, ProQR Therapeutics N.V. holds 2.34B in cash and equivalents against 305.64M in total debt, resulting in a net debt position of -2.24B. Total book value stands at 1.59B, with working capital of 1.73B providing operational flexibility.

ProQR Therapeutics N.V. produced -978.21M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -22.95M in capital expenditures, free cash flow totaled -1.00B - equivalent to -9.55 per share.

These figures cover the twelve months ended June 30, 2026. The operating margin of -233.37 and net profit margin of -228.93 provide insight into operational efficiency.